Here is the complete, richly structured reference covering all 15 topics with diagrams and flowcharts.
Reproductive Physiology - Complete Topic Guide
GROUP A: The Hypothalamo-Pituitary-Gonadal Axis
13. Hypothalamo-Pituitary-Ovarian (HPO) Axis
The HPO axis is the central control system for female reproduction. It operates differently in each phase of the menstrual cycle.
Key Hormones and Their Sources
| Hormone | Source | Action |
|---|
| GnRH (decapeptide) | Hypothalamic arcuate nuclei | Stimulates FSH & LH release (pulsatile) |
| FSH | Anterior pituitary | Granulosa cell growth + estradiol synthesis |
| LH | Anterior pituitary | Ovulation trigger + corpus luteum formation |
| Estradiol (E2) | Granulosa cells | Endometrial proliferation; feedback on HPO |
| Progesterone | Corpus luteum / Placenta | Endometrial secretory phase; negative feedback |
| Inhibin | Granulosa / Sertoli cells | Selective FSH suppression |
Feedback Flowchart - All Three Phases
From Costanzo Physiology 7e - Control of FSH/LH during the menstrual cycle
FOLLICULAR PHASE MIDCYCLE LUTEAL PHASE
───────────────── ───────────────── ─────────────────
Hypothalamus Hypothalamus Hypothalamus
│ GnRH │ GnRH │ GnRH
▼ (+) ▼ (+) ▼ (+)
Ant. Pituitary Ant. Pituitary Ant. Pituitary
│ FSH, LH │ FSH, LH ↑↑ │ FSH, LH
▼ (+) ▼ (+) ▼ (+)
Ovary Ovary Ovary
│ Estradiol ↑ │ Estradiol ↑↑↑ │ Progesterone ↑
└──► (−) feedback └──► (+) feedback └──► (−) feedback
on HPO (LH surge!) on HPO
Key rule: Low estradiol = negative feedback. Estradiol >200 pg/mL = switches to positive feedback, triggering the LH surge and ovulation.
4. Neuroendocrine Reflexes in Reproduction
These are reflex arcs where sensory inputs alter reproductive hormone release.
STIMULUS (sensory input)
│
▼
Neural pathway to hypothalamus
│
▼
GnRH secretion altered
│
▼
FSH/LH altered
│
▼
Gonadal response
Key Neuroendocrine Reflexes
| Reflex | Stimulus | Response | Example |
|---|
| Suckling reflex | Nipple stimulation | Oxytocin release; Prolactin ↑; GnRH ↓ | Lactation-induced anovulation |
| Ferguson reflex | Cervical/vaginal stretch | Oxytocin surge from posterior pituitary | Positive feedback in labor |
| Coital reflex | Copulation | LH surge (in induced ovulators like rabbits) | Reflex ovulation |
| Light/circadian | Photoperiod | Melatonin → GnRH modulation | Seasonal breeding |
| Stress reflex | CRH / cortisol ↑ | GnRH suppression → anovulation | Hypothalamic amenorrhea |
Critical axis:
Stress → ↑CRH → ↑ACTH → ↑Cortisol
│
└──► ↓GnRH → ↓FSH/LH → ↓Ovulation
GROUP B: The Menstrual Cycle
3. Menstrual Cycle
A 28-day cycle divided into two phases around ovulation on Day 14.
Phase Overview
| Phase | Days | Dominant Hormone | Endometrium |
|---|
| Menstrual | 1-5 | E2 & P4 fall | Shedding |
| Proliferative (Follicular) | 5-14 | Estrogen (E2) | Growth, gland elongation |
| Ovulation | Day 14 | LH surge | - |
| Secretory (Luteal) | 14-28 | Progesterone | Tortuous glands, glycogen, edema |
| Premenstrual | 26-28 | E2 & P4 fall | Spiral artery spasm |
Menstrual Cycle Flowchart
Day 1-5: MENSTRUATION
Corpus luteum degenerates → E2 & P4 ↓ → Spiral artery spasm
→ Endometrial necrosis + shedding
│
▼
Day 5-13: FOLLICULAR / PROLIFERATIVE PHASE
FSH ↑ → Follicle grows → E2 ↑
→ Endometrium proliferates (thickness: 1→10 mm)
→ Cervical mucus: watery, copious, "ferning" pattern, sperm-penetrable
│
▼
Day 13-14: OVULATORY PHASE
E2 > 200 pg/mL → Positive feedback → LH SURGE
→ Dominant follicle ruptures (day 14) → Secondary oocyte released
│
▼
Day 14-28: LUTEAL / SECRETORY PHASE
LH → Corpus luteum forms → Progesterone dominates
→ Glands tortuous + glycogen-rich
→ Cervical mucus: thick, non-elastic, non-ferning (blocks sperm)
→ BBT rises ~0.5°C (thermogenic effect of progesterone)
│
┌─────┴──────────────────────┐
│ If fertilized │ If NOT fertilized
▼ ▼
hCG maintains Corpus luteum → Corpus albicans
corpus luteum E2 & P4 fall → DAY 1 again
Cervical Mucus Changes (Clinical Tool)
| Phase | Consistency | Ferning | Spinnbarkeit | Significance |
|---|
| Follicular | Watery, abundant | Yes | >8 cm | Sperm entry permitted |
| Luteal | Thick, scanty | No | <3 cm | Sperm entry blocked |
| Ovulation | Max watery | Max fern | Max stretch | Peak fertility |
5. Mechanism of Ovulation
Ovulation is the rupture of the dominant Graafian follicle releasing the secondary oocyte.
Flowchart
Dominant follicle reaches 20 mm (Day 12-13)
│
▼
Estradiol ≥ 200 pg/mL for ≥ 50 hours
│
▼
POSITIVE FEEDBACK → GnRH pulse frequency ↑
│
▼
ANTERIOR PITUITARY: LH SURGE (10-12x rise)
│
▼
LH acts on follicle → ↑ prostaglandins (PGE2, PGF2α)
→ ↑ proteolytic enzymes (collagenase, plasmin)
→ Resumption of meiosis I in oocyte
│
▼
Follicular wall thins, stigma forms
│
▼
OVULATION: Follicle ruptures (~38 hrs after LH surge)
Secondary oocyte + cumulus oophorus expelled into peritoneum
│
▼
Fimbriae sweep oocyte into fallopian tube
│
▼
LUTEINIZATION: Granulosa + theca cells → Corpus luteum
Corpus luteum secretes Progesterone + Estradiol
Follicular Development Stages
| Stage | Duration | Diameter | Key Event |
|---|
| Primordial follicle | Years (from birth) | <0.03 mm | Primary oocyte arrested in prophase I |
| Primary follicle | Months | 0.1 mm | Granulosa proliferates; trophic FSH effect |
| Secondary (antral) | 70-85 days | 2-5 mm | Antrum forms with fluid; 2-cell/2-gonadotropin theory |
| Graafian follicle | Day 1-12 cycle | 5-20 mm | Dominant follicle selected; E2 surges |
| Ovulation | Day 14 | 20-25 mm | LH surge → rupture |
| Corpus luteum | Day 14-28 | - | Produces P4 for 14 days |
1. Indicators (Tests) of Ovulation and Their Clinical Significance
Table of Ovulation Indicators
| Test | Finding at Ovulation | Timing | Significance |
|---|
| Basal Body Temperature (BBT) | Rise of 0.2-0.5°C | Day after ovulation | Confirms ovulation (retrospective) |
| Cervical mucus (Spinnbarkeit) | >8 cm stretch | Just before ovulation | Peak fertility window |
| Ferning pattern | Crystalline fern pattern | Pre-ovulatory | Due to high E2; disappears post-ovulation |
| Serum LH (urine LH kit) | Sharp surge peak | 24-36 hrs before ovulation | Best predictor - used in fertility kits |
| Serum Progesterone | >3-5 ng/mL | Day 21 of cycle (mid-luteal) | Confirms ovulation occurred |
| Endometrial biopsy | Secretory endometrium | Mid-luteal | Confirms ovulation + adequate luteal phase |
| Ultrasound (USS) | Follicle ≥18 mm → collapses | Periovulatory | Direct visualization of follicle rupture |
| Mid-cycle pain (Mittelschmerz) | Unilateral pelvic pain | Around day 14 | Peritoneal irritation from follicular fluid |
| Vaginal cytology | Eosinophilic shift | Pre-ovulatory | Estrogen effect on vaginal epithelium |
Clinical Significance
- Infertility workup: Day-21 progesterone is the gold standard for confirming ovulation
- Safe period / rhythm method: Uses BBT + mucus pattern to identify infertile days
- ART timing: LH surge detected by urine kits for optimal intercourse/IUI timing
GROUP C: Spermatogenesis and Male Physiology
10. Spermatogenesis
The complete process from spermatogonium to mature sperm takes ~64-74 days total and occurs in the seminiferous tubules.
Spermatogenesis Flowchart
SPERMATOGONIUM (2n, diploid) - Seminiferous tubule basal layer
│ Mitosis (self-renewal + differentiation)
▼
TYPE A SPERMATOGONIUM → TYPE B SPERMATOGONIUM
│ Mitosis
▼
PRIMARY SPERMATOCYTE (2n, 46 chromosomes) - largest germ cell
│ MEIOSIS I (reduction division) - ~22 days
▼
2× SECONDARY SPERMATOCYTES (n, 23 chromosomes)
│ MEIOSIS II - hours
▼
4× SPERMATIDS (n, 23 chromosomes - haploid round cells)
│ SPERMIOGENESIS (~24 days)
│ [Acrosome formation, tail growth, nucleus condensation,
│ cytoplasm shedding, mitochondrial sheath development]
▼
4× MATURE SPERMATOZOA
│
▼ (enter lumen of seminiferous tubule)
EPIDIDYMIS → functional maturation + storage (~12 days)
│
▼
DUCTUS DEFERENS → VAS DEFERENS → URETHRA
Spermiogenesis - Transformation Diagram
Spermiogenesis: Round spermatid → Mature sperm. The Golgi region forms the acrosome; mitochondria arrange into the midpiece sheath. From The Developing Human (Embryology), Moore & Persaud.
Hormonal Regulation
Hypothalamus → GnRH (pulsatile)
│
▼
Anterior Pituitary
├── FSH → Sertoli cells → supports spermatogenesis, secretes Inhibin
└── LH → Leydig cells → Testosterone → (paracrine) supports Sertoli cells
│
▼
TESTOSTERONE (+ FSH) → Complete spermatogenesis
Feedback:
Testosterone → (−) Hypothalamus & Pituitary (↓ GnRH, ↓ LH)
Inhibin → (−) Anterior Pituitary (↓ FSH selectively)
12. Functions of Sertoli Cells
Sertoli cells are "nurse cells" of the seminiferous tubules. They are stimulated by FSH and testosterone.
Summary Table
| Function | Mechanism | Significance |
|---|
| Structural support | Form tight junctions → Blood-Testis Barrier (BTB) | Protects haploid sperm from immune attack |
| Nutritional support | Provide lactate, amino acids, lipids to germ cells | Essential for germ cell survival |
| Phagocytosis | Engulf residual bodies shed during spermiogenesis | Cleans up excess cytoplasm |
| Hormone secretion | Inhibin (↓ FSH), androgen-binding protein (ABP), activin | Fine-tunes spermatogenesis |
| Androgen-binding protein | Concentrates testosterone in seminiferous tubule lumen | Maintains high local T for spermatogenesis |
| Testicular fluid secretion | Creates luminal flow to push sperm toward epididymis | Sperm transport |
| MIF (Müllerian Inhibiting Factor / AMH) | Secreted in fetal life | Causes regression of Müllerian ducts in males |
FSH + Testosterone
│
▼
SERTOLI CELL
┌──────────────────────────────────────┐
│ • Secretes ABP (concentrates T) │
│ • Secretes Inhibin → ↓ FSH │
│ • Secretes MIF/AMH (fetal) │
│ • Secretes transferrin │
│ • Phagocytoses residual bodies │
│ • Forms Blood-Testis Barrier │
│ • Nurtures developing spermatids │
└──────────────────────────────────────┘
GROUP D: Contraception
2. Methods of Contraception (Overview)
CONTRACEPTION METHODS
├── HORMONAL
│ ├── Combined OCP (estrogen + progestogen)
│ ├── Progestogen-only pill (mini-pill)
│ ├── Injectables (DMPA - Depo-Provera)
│ ├── Implants (subdermal progestogen)
│ └── Emergency contraception (levonorgestrel/ulipristal)
│
├── BARRIER
│ ├── Male condom
│ ├── Female condom
│ ├── Diaphragm + spermicide
│ └── Cervical cap
│
├── INTRAUTERINE
│ ├── Copper IUD (non-hormonal)
│ └── Levonorgestrel IUS (Mirena)
│
├── NATURAL / BEHAVIORAL
│ ├── Rhythm/Calendar method
│ ├── Basal body temperature method
│ ├── Billings (cervical mucus) method
│ └── Lactational amenorrhea method (LAM)
│
└── PERMANENT
├── Vasectomy (male)
└── Tubal ligation / Tubectomy (female)
11. Combined Oral Contraceptive Pills (COCP) - Mechanism of Action
Components
- Estrogen component: Ethinyl estradiol (20-35 mcg)
- Progestogen component: Levonorgestrel, norethindrone, desogestrel, drospirenone, etc.
Mechanism Flowchart
COMBINED OCP (Estrogen + Progestogen) taken daily
│
├──► Constant hormone levels
│
▼
1. SUPPRESS HPO AXIS (Primary mechanism)
Estrogen + Progestogen → negative feedback on hypothalamus & pituitary
→ ↓ GnRH pulsatility → ↓ FSH and LH → NO follicular development
→ NO LH surge → NO OVULATION
│
├──► 2. CERVICAL MUCUS THICKENING (Progestogen effect)
│ Thick, hostile mucus → sperm cannot penetrate cervix
│
├──► 3. ENDOMETRIAL CHANGES (Progestogen effect)
│ Thin, atrophic, non-receptive endometrium
│ → Impairs implantation even if fertilization occurs
│
└──► 4. TUBAL MOTILITY CHANGES (minor)
Altered peristalsis → delays sperm/egg transport
Pearl Index (failure rates/100 woman-years)
| Method | Typical use | Perfect use |
|---|
| COCP | 7-9 | 0.3 |
| Progestogen-only pill | 9 | 0.3 |
| Copper IUD | 0.8 | 0.6 |
| Condom (male) | 13 | 2 |
15. Hormonal Contraceptives (Full Classification)
| Type | Route | Hormones | Duration | Mechanism |
|---|
| Combined OCP | Oral daily | E2 + progestogen | Daily | Ovulation suppression + mucus |
| Progestogen-only pill | Oral daily | Progestogen only | Daily | Mucus + partial ovulation suppression |
| Emergency contraceptive | Oral | Levonorgestrel (1.5mg) or Ulipristal | Single dose (within 72/120h) | Delays ovulation; may inhibit implantation |
| DMPA (Depo-Provera) | IM injection | Medroxyprogesterone acetate | 3 months | Ovulation suppression |
| Subdermal implant (Nexplanon) | Subcutaneous | Etonogestrel | 3 years | Ovulation suppression + mucus |
| Hormonal IUS (Mirena) | Intrauterine | Levonorgestrel | 5 years | Local: mucus + endometrium |
| Combined patch | Transdermal | E2 + progestogen | Weekly (3/4 weeks) | Same as COCP |
| Vaginal ring (NuvaRing) | Vaginal | E2 + etonogestrel | Monthly | Same as COCP |
8 & 9. Rhythm Method of Contraception and Safe Period
Both methods exploit the predictable infertile window in the cycle.
Calendar/Rhythm Method
Based on a 28-day cycle:
Ovulation → Day 14
Sperm survival → up to 5 days
Egg survival → 12-24 hours
FERTILE WINDOW = Day 9 to Day 15 (avoid unprotected sex)
SAFE PERIOD = Day 1-8 (post-menstrual) + Day 16-28 (pre-menstrual)
Calculation Rule (for irregular cycles)
Record last 6-12 cycles
Shortest cycle - 18 = First fertile day
Longest cycle - 11 = Last fertile day
e.g., 26-30 day cycles:
First fertile: 26 - 18 = Day 8
Last fertile: 30 - 11 = Day 19
Lactational Amenorrhea Method (LAM)
Three conditions must ALL be met:
- Baby < 6 months old
- Exclusive breastfeeding (day and night)
- Amenorrhea (no periods returned)
Efficacy: >98% when all three criteria met.
GROUP E: Pregnancy, Placenta, and Parturition
6. Physiological Changes During Pregnancy
System-by-System Table (from Morgan & Mikhail's Clinical Anesthesiology)
| System | Change | Clinical Implication |
|---|
| Cardiovascular | Cardiac output +40%; HR +20%; Blood volume +35%; Plasma volume +55% | Physiological anemia; increased cardiac work |
| Blood pressure | Systolic -5%; Diastolic -15%; SVR -15% | Hypotension common; aortocaval compression in supine |
| Respiratory | Minute ventilation +50%; TV +40%; RR +15%; FRC -20% | ↑ PaO2; ↓ PaCO2 (respiratory alkalosis compensated) |
| O2 consumption +20-50%; Airway resistance -35% | Rapid desaturation during apnea |
| Hematological | RBCs +20%; Plasma +55% → Hb -20% (dilutional anemia) | Hb ~11 g/dL is normal; ↑ clotting factors (+30-250%) |
| Coagulation | Hypercoagulable state | VTE risk ↑ 5x; DIC risk in placental abruption |
| Renal | GFR +50%; Creatinine ↓ | Normal creatinine in pregnancy = 0.4-0.8 mg/dL |
| GI | Gastric emptying delayed; LES tone ↓; Progesterone relaxes smooth muscle | Risk of aspiration ↑ |
| Endocrine | hCG surge (first trimester); Estrogen ↑↑↑; Progesterone ↑↑↑; HPL ↑ | Insulin resistance → gestational diabetes risk |
| CNS | MAC (anesthetic requirement) -40% | Reduced drug doses needed |
Hormone Changes Flowchart
CONCEPTION
│
▼
Trophoblast → hCG secretion begins (Day 8-10)
│ hCG peaks at 8-10 weeks
│ hCG maintains corpus luteum
│ → Corpus luteum → E2 + P4
▼
PLACENTA forms (8-10 weeks) → Takes over steroid production
│
├── Progesterone: synthesized entirely by placenta from maternal cholesterol
│ → Maintains uterine quiescence; prevents preterm labor
│
└── Estriol (E3): Requires fetal DHEAS (adrenal) + fetal liver + placenta
→ Used as marker of fetal wellbeing
│
▼
FIRST TRIMESTER: hCG ↑ (morning sickness, thyroid stimulation)
SECOND TRIMESTER: HPL ↑ (insulin resistance, fetal fuel partitioning)
THIRD TRIMESTER: E3 ↑↑, P4 ↑↑, cortisol ↑ (maturation of fetal organs)
14. Functions of the Placenta
The placenta is a transient, highly specialized organ serving as the fetal lung, gut, kidney, liver, and endocrine gland.
PLACENTA FUNCTIONS
├── TRANSPORT
│ ├── O2 delivery to fetus (diffusion, fetal Hb has higher O2 affinity)
│ ├── CO2 removal from fetus
│ ├── Glucose (facilitated diffusion - most important fetal fuel)
│ ├── Amino acids (active transport)
│ ├── Fatty acids (diffusion)
│ ├── IgG (active transport - passive immunity to fetus)
│ └── Water, electrolytes, vitamins
│
├── ENDOCRINE
│ ├── hCG: Maintains corpus luteum; basis of pregnancy test; TSH-like action
│ ├── hPL (Human Placental Lactogen): Insulin antagonist; promotes lipolysis
│ │ (spares glucose for fetus)
│ ├── Progesterone: Uterine quiescence; breast preparation
│ ├── Estrogens (E1, E2, E3): Uterine growth; ductal breast development
│ └── CRH: Drives fetal cortisol production near term; linked to labor onset
│
└── BARRIER (selective)
├── Blocks most maternal antibodies EXCEPT IgG
├── Blocks most bacteria (but NOT viruses like CMV, rubella, HIV)
└── Blocks some drugs (but NOT alcohol, nicotine, warfarin, thalidomide)
7. Parturition
Parturition (labor and delivery) occurs at ~40 weeks gestation. The exact trigger is multifactorial.
Hormonal Mechanism of Parturition
NEAR TERM (38-40 weeks)
│
▼
Fetal hypothalamic-pituitary-adrenal axis activated
│
▼
Fetal cortisol ↑
│
▼
↑ Estrogen : Progesterone ratio in uterus
(Cortisol converts P4 → E2 via placental enzymes)
│
├──► E2 stimulates:
│ • Oxytocin receptors ↑ (up-regulated on uterine muscle)
│ • PGE2 and PGF2α production ↑
│ • Gap junction formation between myometrial cells
│
└──► P4 inhibition removed → Uterus becomes "primed"
│
▼
OXYTOCIN (Ferguson reflex: cervical stretch → oxytocin ↑)
│ + PROSTAGLANDINS
▼
Uterine contractions (coordinate, synchronized via gap junctions)
│
▼
LABOR - THREE STAGES:
Stage 1: Cervical dilation + effacement (longest stage)
Stage 2: Fetal expulsion through birth canal
Stage 3: Placental delivery (+ uterine contraction to stop bleeding)
│
▼
After delivery: E2, P4 fall rapidly → Prolactin ↑ → LACTATION begins
Key Players in Parturition
| Hormone/Mediator | Role |
|---|
| Fetal cortisol | Initiates E2/P4 ratio shift |
| Estrogen | Up-regulates oxytocin receptors, gap junctions, PG synthesis |
| Progesterone | "Uterine quiescence" - its withdrawal allows labor |
| PGE2 / PGF2α | Cervical ripening (effacement + dilation); ↑ intracellular Ca2+ |
| Oxytocin | Powerful uterotonic; receptors up-regulated at term |
| Relaxin | Softens symphysis pubis + cervical collagen |
| CRH | Rises sharply at term; may act as "placental clock" |
GROUP F: Gametogenesis
10. Spermatogenesis (Comparison Table with Oogenesis)
| Feature | Spermatogenesis | Oogenesis |
|---|
| Starts | Puberty | Fetal life (20-24 weeks gestation) |
| Continuous? | Yes - throughout adult life | No - arrested at prophase I until ovulation |
| Pool | Continuously renewed | Fixed pool, declining from birth |
| At birth | Spermatogonia dormant | 2 million oocytes (arrested in prophase I) |
| At puberty | Resumes full production | 400,000 oocytes |
| At menopause | No equivalent | Pool exhausted |
| Products | 4 functional sperm per primary spermatocyte | 1 egg + 3 polar bodies |
| Duration | ~64-74 days | Years (arrested) + 24 hrs |
| Site | Seminiferous tubules | Ovarian follicles |
Summary Flowchart: Integration of All Topics
HYPOTHALAMUS
GnRH (pulsatile)
│
▼
ANTERIOR PITUITARY
FSH ──────────────────────────► Follicle growth (Spermatogenesis in males)
LH ───────────────────────────► Ovulation / Corpus luteum (Testosterone in males)
│ │
│ ┌───────────┘
│ │
▼ ▼
OVARY / TESTIS MENSTRUAL CYCLE (28 days)
E2, P4, Inhibin [Follicular → Ovulation → Luteal → Menstruation]
│
▼ (if fertilized)
PREGNANCY
hCG → maintains corpus luteum
Placenta → E2, P4, hPL, hCG
Physiological changes in all organ systems
│
▼ (at 40 weeks)
PARTURITION
Fetal cortisol → ↑ E2/P4 ratio → Prostaglandins + Oxytocin → Labor
│
▼
LACTATION
Prolactin ↑ (milk production) + Oxytocin (milk ejection)
→ Suckling → ↓ GnRH → Lactational amenorrhea
Quick Reference: Ovulation Indicators + Safe Period Summary
MENSTRUAL CYCLE DAY:
1 5 8 9 13 14 15 16 21 28
│ │ │ │ │ │ │ │ │ │
MENSES │ │ │ │ │ │ │ │
│ FERTILE WINDOW (Days 9-15)│
│ │───────────│ │ │ │
│ │ ↑ LH SURGE (day 13) │
│ │ │ OVULATION (d14) │
│ │ │
PROLIFERATIVE PHASE SECRETORY (LUTEAL) PHASE
(E2 dominance) (P4 dominance + BBT ↑)
BBT: Low until ovulation → Rises 0.5°C on day after ovulation
Ferning: Present Day 8-13 → Absent post-ovulation
Progesterone: Checked Day 21 → >3 ng/mL confirms ovulation
Sources:
- Costanzo Physiology, 7th Edition (Chapters 9-10: Male and Female Reproduction)
- The Developing Human: Clinically Oriented Embryology (Chapter 2: Spermatogenesis, Oogenesis)
- Morgan & Mikhail's Clinical Anesthesiology, 7th Edition (Chapter 40: Physiological Changes in Pregnancy)
- Ganong's Review of Medical Physiology, 26th Edition (Chapter: Menstrual Cycle, Parturition)